Latest news with #AmazfitActive2
Business Upturn
6 days ago
- Business
- Business Upturn
Amazfit Expands Active 2 Lineup with the New Active 2 Square — All the Same Features, Now in a Sleek Square Design
Milpitas, Calif., United States: Amazfit, a leading global smart wearable brand owned by Zepp Health (NYSE: ZEPP), a health technology company, today announced the launch of the square version of the Amazfit Active 2, a new addition to its fitness smartwatch line that offers the same powerful features and premium experience as the recently launched round Active 2 — now in a modern, square form factor. This press release features multimedia. View the full release here: Amazfit Active 2 Square Same Features. New Shape. Debuting at CES 2025 and featured at Pepcom and ShowStoppers, the Active 2 Square is designed for consumers who prefer a bold, geometric aesthetic without compromising performance, durability, or advanced health and fitness tracking. Featuring a square, 1.75 inch sapphire glass high-definition AMOLED display elegantly encased in a polished stainless-steel frame, the Amazfit Active 2 delivers an optimal visual experience with a peak brightness of 2,000 nits, ensuring clarity even in bright light. The graceful metal finish adds a sophisticated touch, perfectly complementing modern, style-conscious lifestyles. Its distinctive geometric form reflects a unique design identity and its intuitive interface and expansive viewing surface provide seamless access to health metrics, messages, and workouts. The device retains the full suite of features that made the round Active 2 a standout. Product Specs Latest Generation Biosensor: The BioTracker™ 6.0 PPG biosensor features a dual-LED and 5PD build, which picks up more biometric signals for enhanced precision in health monitoring and measurement. The BioTracker™ 6.0 PPG biosensor features a dual-LED and 5PD build, which picks up more biometric signals for enhanced precision in health monitoring and measurement. Upgraded Heart Rate and Sleep Algorithms : The PulsePrecision™ algorithm enhances heart rate tracking accuracy to the level of the Amazfit T-Rex 3, while the RestoreIQ™ algorithm gives sleep monitoring a similar accuracy boost. : The PulsePrecision™ algorithm enhances heart rate tracking accuracy to the level of the Amazfit T-Rex 3, while the RestoreIQ™ algorithm gives sleep monitoring a similar accuracy boost. Additional Sensors : Compared to the previous generation of Amazfit Active, the new release adds a barometer for accurate altitude measurements and support of new sports like skiing, along with an accelerometer and gyroscope for precise recognition of sleep and movement, and an ambient light sensor for optimal display under varying light conditions. : Compared to the previous generation of Amazfit Active, the new release adds a barometer for accurate altitude measurements and support of new sports like skiing, along with an accelerometer and gyroscope for precise recognition of sleep and movement, and an ambient light sensor for optimal display under varying light conditions. Extended Battery Life : With a robust 10-day battery life under typical use, the Active 2 Square is a device that won't need recharging every night. : With a robust 10-day battery life under typical use, the Active 2 Square is a device that won't need recharging every night. Zepp Flow™: Enables users to control their watch settings, adjust their calendar, and more with just their voice, while also granting Android users the ability to reply to instant messages with either keyboard or speech-to-text input. Fitness and Wellness Features Dynamic Fitness Modes : Over 160 sports modes including official HYROX Race Mode, a smart Strength Training mode that can auto-detect specific exercises and intelligently count reps, sets, and rest time, and new winter sports like Skiing. : Over 160 sports modes including official HYROX Race Mode, a smart Strength Training mode that can auto-detect specific exercises and intelligently count reps, sets, and rest time, and new winter sports like Skiing. Offline Maps with Turn Directions: Supported by 5 satellite systems, users can navigate with ease by importing offline maps and route files to the watch that come with turn-by-turn directions, which can be followed on-screen or broadcast via the built-in speaker or the user's connected Bluetooth headphones. Supported by 5 satellite systems, users can navigate with ease by importing offline maps and route files to the watch that come with turn-by-turn directions, which can be followed on-screen or broadcast via the built-in speaker or the user's connected Bluetooth headphones. Zepp Coach™ Integration : Offers personalized training and running plans, empowering users of all levels to achieve fitness milestones from 3K runs to full marathons. : Offers personalized training and running plans, empowering users of all levels to achieve fitness milestones from 3K runs to full marathons. Tailored for Women : With the mini app, women can connect to their accounts directly from the watch for personalized wellness insights tied to their menstrual and hormonal cycles. : With the mini app, women can connect to their accounts directly from the watch for personalized wellness insights tied to their menstrual and hormonal cycles. Advanced Health Insights: A daily Readiness score summarizes mental and physical recovery and provides actionable insights, while the HRV feature delivers specialized recovery data. Availability and Pricing The Amazfit Active 2 Square is available for purchase beginning today on and Amazon . Priced at $149.99 USD or €149.90 euro, the Active 2 Square delivers premium features and performance at an unbeatable value. For more information, please visit and follow us on Facebook , Instagram , X (formerly Twitter) and YouTube . About Amazfit Amazfit, a leading global smart wearable brand focused on health and fitness, is part of Zepp Health (NYSE: ZEPP), a health technology company with its principal office based in Gorinchem, the Netherlands. Zepp Health operates as a distributed organization, with team members and offices across the Americas, Europe, Asia, and other global markets. Offering a wide selection of smartwatches and bands, Amazfit's brand tagline, 'Discover Amazing,' encourages individuals to break barriers, exceed expectations, and find joy in every moment. Amazfit is powered by Zepp Health's proprietary health management platform, which delivers cloud-based, 24/7 actionable insights and guidance to help users achieve their wellness goals. Known for outstanding craftsmanship, Amazfit smartwatches have won numerous design awards, including the iF Design Award and the Red Dot Design Award. Launched in 2015, Amazfit is embraced by millions of users, with products available in over 90 countries across the Americas, EMEA, and APAC regions. For more information, visit . View source version on Disclaimer: The above press release comes to you under an arrangement with Business Wire. Business Upturn takes no editorial responsibility for the same. Ahmedabad Plane Crash
Business Wire
6 days ago
- Business
- Business Wire
Amazfit Expands Active 2 Lineup with the New Active 2 Square — All the Same Features, Now in a Sleek Square Design
MILPITAS, Calif.--(BUSINESS WIRE)--Amazfit, a leading global smart wearable brand owned by Zepp Health (NYSE: ZEPP), a health technology company, today announced the launch of the square version of the Amazfit Active 2, a new addition to its fitness smartwatch line that offers the same powerful features and premium experience as the recently launched round Active 2 — now in a modern, square form factor. Featuring a square, 1.75 inch sapphire glass high-definition AMOLED display elegantly encased in a polished stainless-steel frame. Share Same Features. New Shape. Debuting at CES 2025 and featured at Pepcom and ShowStoppers, the Active 2 Square is designed for consumers who prefer a bold, geometric aesthetic without compromising performance, durability, or advanced health and fitness tracking. Featuring a square, 1.75 inch sapphire glass high-definition AMOLED display elegantly encased in a polished stainless-steel frame, the Amazfit Active 2 delivers an optimal visual experience with a peak brightness of 2,000 nits, ensuring clarity even in bright light. The graceful metal finish adds a sophisticated touch, perfectly complementing modern, style-conscious lifestyles. Its distinctive geometric form reflects a unique design identity and its intuitive interface and expansive viewing surface provide seamless access to health metrics, messages, and workouts. The device retains the full suite of features that made the round Active 2 a standout. Product Specs Latest Generation Biosensor: The BioTracker™ 6.0 PPG biosensor features a dual-LED and 5PD build, which picks up more biometric signals for enhanced precision in health monitoring and measurement. Upgraded Heart Rate and Sleep Algorithms: The PulsePrecision™ algorithm enhances heart rate tracking accuracy to the level of the Amazfit T-Rex 3, while the RestoreIQ™ algorithm gives sleep monitoring a similar accuracy boost. Additional Sensors: Compared to the previous generation of Amazfit Active, the new release adds a barometer for accurate altitude measurements and support of new sports like skiing, along with an accelerometer and gyroscope for precise recognition of sleep and movement, and an ambient light sensor for optimal display under varying light conditions. Extended Battery Life: With a robust 10-day battery life under typical use, the Active 2 Square is a device that won't need recharging every night. Zepp Flow™: Enables users to control their watch settings, adjust their calendar, and more with just their voice, while also granting Android users the ability to reply to instant messages with either keyboard or speech-to-text input. Fitness and Wellness Features Dynamic Fitness Modes: Over 160 sports modes including official HYROX Race Mode, a smart Strength Training mode that can auto-detect specific exercises and intelligently count reps, sets, and rest time, and new winter sports like Skiing. Offline Maps with Turn Directions: Supported by 5 satellite systems, users can navigate with ease by importing offline maps and route files to the watch that come with turn-by-turn directions, which can be followed on-screen or broadcast via the built-in speaker or the user's connected Bluetooth headphones. Zepp Coach™ Integration: Offers personalized training and running plans, empowering users of all levels to achieve fitness milestones from 3K runs to full marathons. Tailored for Women: With the mini app, women can connect to their accounts directly from the watch for personalized wellness insights tied to their menstrual and hormonal cycles. Advanced Health Insights: A daily Readiness score summarizes mental and physical recovery and provides actionable insights, while the HRV feature delivers specialized recovery data. Availability and Pricing The Amazfit Active 2 Square is available for purchase beginning today on and Amazon. Priced at $149.99 USD or €149.90 euro, the Active 2 Square delivers premium features and performance at an unbeatable value. For more information, please visit and follow us on Facebook, Instagram, X (formerly Twitter) and YouTube. About Amazfit Amazfit, a leading global smart wearable brand focused on health and fitness, is part of Zepp Health (NYSE: ZEPP), a health technology company with its principal office based in Gorinchem, the Netherlands. Zepp Health operates as a distributed organization, with team members and offices across the Americas, Europe, Asia, and other global markets. Offering a wide selection of smartwatches and bands, Amazfit's brand tagline, 'Discover Amazing,' encourages individuals to break barriers, exceed expectations, and find joy in every moment. Amazfit is powered by Zepp Health's proprietary health management platform, which delivers cloud-based, 24/7 actionable insights and guidance to help users achieve their wellness goals. Known for outstanding craftsmanship, Amazfit smartwatches have won numerous design awards, including the iF Design Award and the Red Dot Design Award. Launched in 2015, Amazfit is embraced by millions of users, with products available in over 90 countries across the Americas, EMEA, and APAC regions. For more information, visit
Mint
12-06-2025
- Health
- Mint
Amazfit Active 2 smartwatch review: Loaded with features, light on price
I've always had a complicated relationship with smartwatches — especially those that come in a standard size. For years, I've found myself caught between wanting the latest features and the comfort of a wearable that doesn't feel like a burden. Most smartwatches, even the ones marketed as 'unisex' or 'compact,' have ended up feeling too large on my wrist. This frustration became especially clear when I started wearing the Amazfit Balance. While it offered a wealth of features and impressive health tracking, it always felt a bit too big and heavy—like I was wearing a miniature computer rather than an accessory. The Velcro strap, though practical, wasn't the easiest to keep clean, and after a while, I found myself longing for something lighter, sleeker, and more comfortable. You may be interested in That's when I decided to give the Amazfit Active 2 a try. Compared to its square-shaped predecessor, the watch is now round. It looked more compact and stylish from the get-go, and while these are variables worth considering, there's a lot more to a smartwatch than good looks. Keep reading to find out. The stainless steel body and glossy glass face gave it a premium, almost timeless look — like a classic watch, but with all the modern features I'd come to expect. More importantly, it felt like a feather on my wrist. Even after wearing it all day — and even to bed — it never felt like it was choking me or getting in the way. The glass is shiny and glossy, encased in a sleek stainless steel body that gives it a classic, refined look. The 1.32' AMOLED display is a real standout. In bright sunny conditions, the 1.32' AMOLED screen is actually easier to read than my iPhone 15, all thanks to its2,000 nits of I'm out for a walk with my dog or just checking notifications in direct sunlight, the screen stays crisp and vibrant, making it a pleasure to use no matter where I am. With the Amazfit Active 2, I finally feel like I've found a smartwatch that fits my wrist and my lifestyle. I have a lot of day-to-day anxiety, and the high heart rate alerts on the watch help me zone out and take deep breaths - all while observing my heart rate go down in real time. This is a standard feature on most smartwatches though, it's only a question of how well it works on which watch. And on the Active 2, it does a fairly good job - although, one must be wary of not mistaking these metrics as facts because this is not a medical device. It's best to check with your doctor if you're looking for complete accuracy. For once, the dial is the perfect size for my wrist. I've been using the Amazfit Balance before this, and while it's a great watch, it always felt a bit huge — like I was wearing a gadget rather than an accessory. The Active 2, on the other hand, sits just right — lightweight and unobtrusive, so I barely notice it's there, whether I'm running down the stairs or sleeping. The silicone strap is a real kicker for me. It's easier to clean, especially after sweaty workouts, and it stays secure without feeling tight. I appreciate that it's skin-friendly and resists moisture, which is a relief when I'm running or lifting - and I don't have to constantly keep washing the strap. Here's all you need to know about the Amazfit Active 2. One of my biggest gripes with smartwatches has always been battery life — I hate having to remember to charge yet another device every night. With the Amazfit Active 2, that's no longer a concern. I'm getting up to 6-7 days on a single charge with typical use, and even when I push it with 24x7 tracking and more. I've worn it for days on end, tracking sleep, steps, and notifications, and I've only had to recharge it once a week. It can also fully charge in under 2 hours. The only negative I've found is that I do miss the dial on the side that the Amazfit Balance had. It made navigation a bit quicker and gave the watch a more premium feel. With the Active 2, it's all touch and two buttons, which works fine, but I do feel the absence of that extra control sometimes. The maps app, while a standout feature for the price, isn't as slick as I'd hoped. You can't pinch-to-zoom or swipe to move around — street names and parks are labelled, but points of interest often aren't, and you can't just tap to navigate to a spot. To get turn-by-turn directions, you have to import a route file from another app, which feels needlessly fussy. In practice, the watch only reminded me to turn about half the time, and deviation warnings were hit or miss unless I tweaked the settings. Also, there's no way to see which apps are running or close ones you don't need, which can be frustrating if you get stuck in a menu. Swiping left to right is supposed to take you back, but I often found myself trapped in apps, relying on the physical buttons to escape. The Active 2 doesn't have Wi-Fi, so some features — like the AI voice assistant — only work with your phone nearby and the Zepp app open. It's not ideal if you want to leave your phone at home. Despite these quirks, offline maps and turn-by-turn directions are rare at this price, and the physical buttons are always responsive. For the occasional backup, it's a useful feature — just don't expect it to replace your phone for navigation. Tracking on the Active 2 is on point. The app tells me how much I've slept, the quality of my sleep, and when my stress is high. I even get notifications to do calming exercises or listen to calming music — a thoughtful touch that helps me manage stress better. Heart rate variability is also measured, and there are notifications in place to alert me if anything is too high. Of course, all of this can be tweaked from the app, so I can set it up just the way I like. The Zepp App is free and packed with features. It organises my health data neatly, so I can see trends over time and understand my progress. I like that I can review my sleep stages, stress levels, and workouts all in one place. I've come to depend on my smartwatches to see how well I'm sleeping and how much sleep I've got, so this is a really important feature for me. I found that it works as well as the Amazfit Balance, but there's no way to really verify the accuracy of sleep quality and duration analysis. But mostly, the sleeping and wake up times are in sync with my reality. Overall, the app's guidance and analysis are helpful. The Amazfit Active 2 is a smartwatch that fits my wrist and my lifestyle. It's comfortable, easy to use, and packed with features that help me stay on top of my health. The bright, glossy display and premium build make it a pleasure to wear, and the only thing I really miss is the side dial from my old watch. This watch is priced at ₹ 21,999 but can be purchased for ₹ 9,999 on the Amazfit website.
Tom's Guide
26-05-2025
- Tom's Guide
I test smartwatches for a living — and these are my 5 favorite models when I go hiking
You don't need to break the bank to score a solid smartwatch for tracking hikes and other outdoor adventures. Models like the $99 Amazfit Active 2 have all the basics like onboard GPS, offline maps and solid battery life. However, higher-end models like the Garmin Instinct 3 and Apple Watch Ultra 2 bring exceptional durability and other nifty features — including a built-in LED flashlight on the Garmin — into the equation. Want something supremely comfortable and reliable? The Garmin Forerunner 165 might be your jam. Having tested dozens of smartwatches while hiking the mountains of the U.S. Pacific Northwest, I know firsthand which models are primo trail companions and which are better left in the car. With that, here are my five favorite smartwatches for hikers in 2025. The Garmin Instinct 3 is one of my favorite smartwatches currently available. This is thanks to its rock-solid location tracking, range of useful wellness tools, support for tons of outdoor activities, and, perhaps most importantly, its long-lasting nature. The Instinct 3 comes in several varieties, including with optional solar charging capabilities. With enough time in front of the sun, the Instinct 3 Solar can, in theory, last forever without needing to visit a wall outlet or USB slot. The standard AMOLED model, meanwhile, will keep on ticking for well over two weeks. The device is also built to take on whatever the outdoors can toss at it, with 100 meters of water resistance and an oversized metal reinforced bezel to protect the screen. The Garmin Instinct 3 starts at $399 for the smaller 45mm Solar model and increases to $449 for the larger 50mm Solar edition. The 45mm AMOLED model is $449, and the larger 50mm AMOLED version is $499. The Garmin Forerunner 165 is technically a mid-entry-level running watch, but all the things that make it great for first-time marathoners also make it exceptional for hikers Get instant access to breaking news, the hottest reviews, great deals and helpful tips. Stacked with some of Garmin's best workout training and recovery tools, not to mention impressive sleep tracking capabilities, it's also an exceptional value, easily found for under $200. For hikers, in particular, it keeps tabs on key metrics like elevation gain, pace and distance. It also has safety features, including LiveTrack and Incident Detection. Battery life when using GPS tracking should also be good for even the longest day hikes, up to 19 hours. It also comes in two lightweight, easy-wearing sizes and boasts a bright AMOLED touchscreen paired with physical buttons for when your hands are extra sweaty mid-hike. The Garmin Forerunner 165 starts at $249 but can often be found for $50 off. There's also a Music edition of the Forerunner 165, which has, you guessed it, onboard storage for tunes. That model will cost you an extra $50, but like the standard model, it often goes on sale. If you want a super-rugged smartwatch that'll take a licking and keep on ticking (okay, that's an old Timex slogan) without spending Apple Watch Ultra 2-type cash, then the Amazfit T-Rex 3 is worth a look. This oversized beast has a massive 1.5-inch AMOLED touchscreen that maxes out at an impressive 2,000 nits. This is paired with a whole bunch of physical buttons, all tucked nearly into a rather cool-looking octagonal case with a big ol' stainless steel bezel. Battery life with GPS tracking should easily get you through 36 hours or more of hiking. With 100 meters of water resistance, dual-band GPS, and even support for offline navigational maps, it's kind of amazing that the T-Rex 3 can be yours for around $250. The beastly Amazfit T-Rex 3 is priced at $279 but can easily be acquired for between $25 and $50 off. It only comes in one size, and though the nearly 49mm case won't be for everyone, the T-Rex 3 is a mighty-fine alternative to the Apple Watch Ultra 2. The Amazfit Active 2 has nearly all the same bells and whistles as the T-Rex 3, just squeezed into a more streamlined, easy-wearing case. Starting at less than $100, this admittedly handsome-looking smartwatch has onboard GPS, supports 160+ workout types, sports a bright AMOLED touchscreen and can track a hearty day's workout with plenty of battery to spare, making it one of the best bang-for-your-buck wearables in 2025. However, the most shocking feature, given the price, is support for offline navigational maps. While a little rough around the edges and somewhat limited in capability compared to, say, Apple, Garmin and Google's take, this is a tool ordinarily only found on far pricer smartwatch models. Also worth noting: Amazfit is very good about responding to user feedback with firmware updates, and even within the few months that have passed since I reviewed the Active 2, it's already seen several enhancements. The Amazfit Active 2 comes in two variants. The standard $99 model has an aluminum case and glass screen. The higher-end Active 2 premium edition ups the ante with a tougher sapphire crystal screen and stainless steel case for an extra $30. Neither Garmin nor Amazfit makes smartwatches with cellular connectivity. Fortunately, brands like Apple, Samsung and Google do. My favorite cellular-connected smartwatch is the Apple Watch Ultra 2. Similar to the best Garmin watches, the Ultra 2 is jam-packed with impressive safety features, like fall and crash detection, along with Emergency SOS. It also makes for a mighty good hiking partner thanks to a long-lasting battery — up to 35 hours when tracking a hike with GPS enabled — a tough-built design with 100 meters of water resistance, and accurate location and holistic tracking. You also get a sweet, customizable 'Action' button (plus, a side button and digital crown) along with a super-bright and immersive touchscreen. The Apple Watch Ultra 2 comes in a variety of case colors, including black (shown here), each for $799. Cellular connectivity comes standard, though you're not required to have a data plan to use the Ultra 2.
Yahoo
20-05-2025
- Business
- Yahoo
Zepp Health Corporation Reports First Quarter 2025 Unaudited Financial Results
MILPITAS, Calif., May 19, 2025 /PRNewswire/ -- Zepp Health Corporation ("Zepp" or the "Company") (NYSE: ZEPP) today announced its unaudited financial results for the first quarter of 2025. First Quarter 2025 Financial and Operating Highlights: Revenue reached US$39 million, out of which Amazfit-branded products grew by 10.2% year-over-year. Gross margin was 37.3% compared with 36.8% in the same period of last year Cash balance was 104 million, after repayment of US$11.5 million short-term debt in the first quarter of 2025. The U.S.-China reached deal to temporarily reduce tariffs; the company has proactively established a dual-sourcing supply chain strategy with production bases in both China and Vietnam. For the second quarter of 2025, the Company's management currently expects net revenues to be between US$50 million and US$55 million, which would represent an increase of approximately 23% to 35% from US$40.6 million in the second quarter of 2024. Mr. Wang 'Wayne' Huang, Chairman and CEO of Zepp, commented, "In the first quarter of 2025, we are happy to see that our Amazfit revenue grew 10% year over year as we execute against a difficult macro backdrop while sharpening our operating model for long–term resilience. Tariff relief on key smartwatch categories in the United States and our dual–sourcing strategy between China and Vietnam helped cushion some external cost pressures, and the additional Vietnam capacity we brought online further de–risked the supply chain. Fixed expenses were not fully absorbed in the low season, which limited gross–margin leverage, but the progress we have made on mix upgrade keeps us firmly on the path toward sustained profitability." Wayne added, "Over the past four months, we successfully launched the Amazfit Active 2 and Bip 6. These smartwatches frequently rank among the top 10 on Amazon's smartwatch category in major countries with ratings exceeding 4.6 on Amazon in the U.S. They also received enthusiastic acclaim within the Reddit community. With sales on a consistent upward trend and production - delivery challenges on the brink of full resolution, we anticipate even higher sales for the Active 2 and Bip 6 series in the upcoming quarters. We remain committed to leveraging open-source technologies such as Llama. Recently, we enhanced the responsiveness of Zepp Flow voice commands on our smartwatches, achieving a 17-fold improvement in speed. Additionally, by adopting a hybrid AI solution combining OpenAI and Google Gemini, we reduced the cost of food recognition in our app's food log by 90%. This enabled us to expand the service across a wider region in Europe and double the daily usage allowance for users." Wayne concluded, "To amplify the brand, we deepened our presence in the HYROX community via events in Chicago, Taipei and Shanghai, and welcomed global athlete partners like five-time Olympic medallist Gabby Thomas and Italian tennis star Jasmine Paolini. Last weekend, Jasmine made history by becoming the first Italian woman in 40 years to win the Rome Open. She, wearing the Active 2 watch, is inspiring sports enthusiasts in the spotlight. Such moments build brand voice and user connection. Strong sales of our budget-friendly products lay the groundwork for mid-to-high-end launches, strengthen partner confidence, broaden our user base, and expand the sales funnel. As these efforts begin to yield in results, second quarter we expect our first year-over-year overall sales growth since 2021 as new products scale up, partnerships expand, and our global footprint broadens. We'll remain vigilant of external challenges, keep optimizing the supply chain, and invest in AI-driven unique experiences to keep Zepp Health leading in the wearable market. With all the new product roadmaps lined up, and we believe 2025 will be a fruitful year for Zepp Health." Zepp Health's CFO, Mr. Leon Deng, said, "Our results in the first quarter of 2025 tracked closely with guidance. We are pleased to report that Amazfit products revenue has returned to growth after a two-year transformation period. This marks a significant milestone in our ongoing strategy toward a more brand-driven growth model. The strong performance reflects continued momentum in our core markets and the successful launches of key products, which have outperformed prior models in terms of sales velocity and market reception. Total gross margin stood at 37.3%, higher than both the fourth and the first quarter of 2024, even after absorbing foreign currency and tariffs headwinds. Furthermore, our total operating expense was US$32.7 million, and adjusted operating expenses[1] of US $31.5 million in the first quarter were up modestly from both the prior quarter and prior year same quarter, reflecting disciplined investments in research and development expenses, as well as targeted brand and marketing investments around product launches and new athlete sponsorships. As a result, our net loss is US$19.7 million, and our adjusted net loss[2] was US$18.1 million, as the first quarter is traditionally the lowest sales season for consumer electronics industry, which could not absorb our cost base in full. Despite this, our cash balance was US$104 million, compared to US$110 million at the fourth quarter of 2024, thanks to our enhanced working capital management and improved cash conversion cycle. Following the refinancing completed in February, long–term borrowings now represent about 70% of our total debt, and we have retired US$67.8 million of debt since early 2023, with another US$11.5 million repaid in the first quarter 2025. For the second quarter, we project revenue of US$50 million to US $55 million, representing 23% to 35% growth of revenues compared with second quarter of 2024. Our share‑repurchase program remains in place for the remainder of 2025, underscoring confidence in Zepp Health's outlook. " [1] Adjusted operating expenses represent operating expenses excluding (i) share-based compensation expenses and (ii) amortization of intangible assets resulting from acquisitions and business cooperation agreements. See "Reconciliation of GAAP and non-GAAP results" at the end of this press release. [2] Adjusted net income/(loss) attributable to Zepp Health Corporation represents net income/(loss) excluding (i) share-based compensation expenses, (ii) amortization of intangible assets resulting from acquisitions and business cooperation agreements, (iii) gain/(loss) from fair value change of long-term investment, (iv) impairment loss from long-term investments, (v) income/(loss) from equity method investments, and (vi) tax effects of the above non-GAAP adjustments. See "Reconciliation of GAAP and non-GAAP results" at the end of this press release. First Quarter 2025 Financial Results Revenues Revenues for the first quarter of 2025 reached US$38.5 million, a decrease by 3.6% from the first quarter of 2024. The decrease was primarily due to the US$5.0 million decrease in the sales of Xiaomi wearable products. In the first quarter of 2025, sales of Amazfit-branded products grew 10.2% year over year, marking a return to growth since the first quarter of 2022. This was preceded by a strong quarter over quarter growth of 43.4% from the third quarter to the fourth quarter of 2024. The increase was mainly driven by the successful launch of Amazfit Active 2, Bip 6, while we are still facing some supply constrains especially on the Amazfit Active 2 premium version, and it should be fully resolved in the second quarter of 2025. Compared with fourth quarter of 2024, revenue decline is driven by the seasonality while the first quarter is the lowest quarter of the year and supply constrains especially on the long lead-time components for Amazfit Bip 6 and Active 2 premium version, which resulted the Bip 6's launch was postponed to the end of March 2025. Looking at the second quarter of 2025, we are expecting the Amazfit-branded sales continue to grow, with many new products launches in the pipeline. Gross Margin Gross margin in the first quarter of 2025 was 37.3%, which was higher than first and fourth quarter of 2024, We are impacted by the additional 20% tariffs imposed on China-made products in the first quart of 2025, excluding that the gross margin is 38.4%. The higher gross margin of Amazfit-branded products was mainly driven by the higher gross margin of newly- launched products. Research and Development Expenses Research and development expenses in the first quarter of 2025 were US$12.4 million, a decrease by 7.8% year-over-year. The decrease was as a result of our refined research and development approaches, as we consistently evaluated resource efficiency to ensure maximum return on investment and productivity. We are committed to investing in new technologies and AI to maintain our competitive edge against our peers. Selling and Marketing Expenses Selling and marketing expenses in the first quarter of 2025 were US$13.8 million, an increase by 28.5% year-over-year. The increase was primarily due to US$1.7 million in digital campaigns and product launch events for new products, and US$1.4 million in sales channel investments. At the same time, we consistently pushed on retail profitability and channel mix improvement. We are committed to investing efficiently in marketing and branding to ensure our sustainable growth. General and Administrative Expenses General and administrative expenses were US$6.5 million in the first quarter of 2025, compared with US$6.4 million in the same period of 2024, an increase by 1.5% year-over-year. The increase was largely attributable to foreign exchange rate fluctuations of US$1.0, offset by a US$0.8 million decrease in share-based compensation expenses. Operating Expenses Total operating expenses for the first quarter of 2025 were US$32.7 million, an increase by 6.9% year-over-year. Adjusted operating expenses, which exclude share-based compensation and amortization of intangible assets resulting from acquisitions and business cooperation agreements, were US$31.5 million, compared with US$27.8 million in the same period of 2025. The increase was primarily due to foreign exchange rate fluctuations of US$1.0 million, US$1.7 million in digital campaigns and product launch events for new products, and US$1.4 million in sales channel investments. We will maintain our cost-conscious approach, aiming for operating expenses of US$25 to US$27 million in the upcoming quarters. Concurrently, we remain committed to investing in R&D and marketing activities to ensure our long-term competitiveness. Operating Income/(Loss) Operating loss for the first quarter of 2025 was US$18.4 million, which resulted in an inability to fully cover operating expenses, compared to operating loss of US$15.9 million for the first quarter of 2024. Adjusted operating loss[3] for the first quarter of 2025 was US$17.2 million, compared to adjusted operating loss of US$13.1 million for the same period of 2024. The variance was mainly due to foreign exchange rate fluctuations of US$1.0 million, US$1.7 million in digital campaigns and product launch events for new products, and US$1.4 million in sales channel investments. [3] Adjusted operating income/(loss) represents operating income/(loss) excluding: (i) share-based compensation expenses and (ii) amortization of intangible assets resulting from acquisitions and business cooperation agreements. See "Reconciliation of GAAP and non-GAAP results" at the end of this press release. Net Income/(Loss) Net loss attributable to Zepp Health Corporation for the first quarter of 2025 was US$19.7 million, compared to net loss of US$14.8 million in the first quarter of 2024. Adjusted net loss attributable to Zepp Health Corporation was US$18.1 million, compared to adjusted net loss of US$13.6 million in the first quarter of 2024. The first quarter is typically the season with the lowest sales, which resulted in an inability to fully cover operating expenses. Liquidity and Capital Resources As of March 31, 2025, the Company had cash and cash equivalents and restricted cash of US$103.8 million, compared with US$110.7 million of cash balance as of December 31, 2024, the result was driven by the net loss for the first quarter of 2025, offset by US$12.8 million tighter working capital management. This cash position provides ample runway for the Company to invest and seize potential market opportunities. The Company continued to manage its working capital and inventory efficiently and recorded inventory of US$64.1 million as of March 31, 2025. It went up a bit due to preparation for product launch, but the Company managed to improve big time on accounts receivable collection and accounts payable management. The Company will continue to manage working capital tightly. By February 2025, we have successfully refinanced majority of our short-term debts maturing in 2025 to a multi-year long-term debt maturing in 2027 and beyond with a lower interest rate. Starting the first quarter of 2023, we have initiated the retirement of our short/long-term debt portfolio. As of the first quarter of 2025, the Company has retired a total of US$67.8 million of debt since early 2023, with US$11.5 million repaid in the first quarter of 2025. As our operating cash flow continues to strengthen, we will continue to optimize the capital structure for the company. Shares Outstanding As of March 31, 2025, the Company had a total of 229.9 million ordinary shares outstanding, representing the equivalent of 14.4 million ADSs assuming the conversion of all ordinary shares into ADSs. Share Repurchase Program Update The Company announced in its third quarter 2021 earnings release that the board had authorized a share repurchase program of up to US$20 million through November 2022. On November 21, 2022, the board authorized a 12-month extension of the Company's share repurchase program. On November 20, 2023, the board further authorized the Company to extend its share repurchase program for another 12 months. On November 18, 2024, the board further authorized the Company to extend its share repurchase program for another 24 months. Pursuant to the extended share repurchase program, the Company may repurchase its shares in the form of ADSs and/or ordinary shares through November 2026 with an aggregate value equal to the remaining balance under the share repurchase program. As of March 31, 2025, the Company had used US$15.4 million to repurchase approximately 2.0 million ADSs. The Company expects to fund the repurchases under the extended share repurchase program out of its existing cash balance. Outlook For the second quarter of 2025, the Company's management currently expects net revenues to be between US$50 million and US$55 million, which would represent an increase of approximately 23% to 35% from US$40.6 million in the second quarter of 2024. This outlook is based on current market conditions and reflects the Company's current and preliminary estimates of market, operating conditions and customer demand, which are all subject to change. Conference Call The Company's management team will hold a conference call at 9:00 p.m. Eastern Time on Wednesday, May 19, 2025 to discuss financial results and answer questions from investors and analysts. Listeners may access the call by dialing: US (Toll Free): +1-888-346-8982 International: +1-412-902-4272 Mainland China (Toll Free): 400-120-1203 Hong Kong (Toll Free): 800-905-945 Hong Kong: +852-3018-4992 Participants should dial in at least 10 minutes before the scheduled start time and ask to be connected to the call for "Zepp Health Corporation". Additionally, a live and archived webcast of the conference call will be available at A telephone replay will be available one hour after the call until May 26, 2025 by dialing: US Toll Free: +1-877-344-7529 International: +1-412-317-0088 Replay Passcode: 5798726 About Zepp Health Corporation Zepp Health Corporation (NYSE: ZEPP) is a global smart wearable and health technology leader, empowering users to live their healthiest lives by optimizing their health, fitness, and wellness journeys through its leading consumer brands, Amazfit, Zepp Clarity and Zepp Aura. Powered by its proprietary Zepp Digital Management Platform, which includes the Zepp OS, AI chips, biometric sensors and data algorithms, Zepp delivers cloud-based 24/7 actionable insights and guidance to help users attain their wellness goals. To date, Zepp has shipped over 200 million units, and its products are available in more than 90 countries and regions. Founded in 2013 as Huami Corp., the Company changed its name to Zepp Health Corporation in February 2021 to emphasize its health focus with a name that resonates across languages and cultures globally. Zepp has team members and offices across globe, especially in Europe and USA regions. Use of Non-GAAP Measures We use adjusted net income/(loss), a non-GAAP financial measure, in evaluating our operating results and for financial and operational decision-making purposes. Adjusted operating expenses represent operating expenses excluding (i) share-based compensation expenses and (ii) amortization of intangible assets resulting from acquisitions and business cooperation agreements. Adjusted operating income/(loss) represents operating income/(loss) excluding: (i) share-based compensation expenses and (ii) amortization of intangible assets resulting from acquisitions and business cooperation agreements. Adjusted EBIT[4] represents net income/(loss) excluding (i) share-based compensation expenses, (ii) amortization of intangible assets resulting from acquisitions and business cooperation agreements, (iii) gain/(loss) from fair value change of long-term investment, (iv) impairment loss from long-term investments, (v) income/(loss) from equity method investments, (vi) income tax (benefit)/expense, and (vii) interest income and interest expense. Adjusted net income/(loss) attributable to Zepp Health Corporation is a non-GAAP measure, which excludes (i) share-based compensation expenses, (ii) amortization of intangible assets resulting from acquisitions and business cooperation agreements, (iii) gain/(loss) from fair value change of long-term investment, (iv) impairment loss from long-term investments, (v) income/(loss) from equity method investments, and (vi) tax effects of the above non-GAAP adjustments, and is used as the numerator in computation of adjusted net income/(loss) per share and per ADS attributable to Zepp Health Corporation. We believe that adjusted EBIT and adjusted net income/(loss) attributable to Zepp Health Corporation help identify underlying trends in our business that could otherwise be distorted by the effect of certain expenses that we include in net income/(loss) and net income/(loss) attributable to Zepp Health Corporation. We believe adjusted EBIT and adjusted net income/(loss) attributable to Zepp Health Corporation provides useful information about our operating results, enhances the overall understanding of our past performance and future prospects and allows for greater visibility with respect to key metrics used by our management in its financial and operational decision-making. Adjusted EBIT and adjusted net income/(loss) attributable to Zepp Health Corporation, should not be considered in isolation or construed as an alternative to net income/(loss), basic and diluted net income/(loss) per share and per ADS attributable to Zepp Health Corporation or any other measure of performance or as an indicator of our operating performance. Investors are encouraged to review the historical non-GAAP financial measures to the most directly comparable GAAP measures. Adjusted EBIT and adjusted net income/(loss) attributable to ordinary shareholders, presented here may not be comparable to similarly titled measures presented by other companies. Other companies may calculate similarly titled measures differently, limiting their usefulness as comparative measures to our data. We encourage investors and others to review our financial information in its entirety and not rely on a single financial measure. [4] Adjusted EBIT is a non-GAAP financial measure, which is defined as net loss, excluding (i) share-based compensation expenses, (ii) amortization of intangible assets resulting from acquisitions and business cooperation agreements, (iii) gain/(loss) from fair value change of long-term investment, (iv) impairment loss from long-term investments, (v) income/(loss) from equity method investments, (vi) income tax (benefit)/ expense, and (vii) interest income and interest expense. Safe Harbor Statement This announcement contains forward-looking statements. These statements are made under the "safe harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as "will," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates," "confident" and similar statements. Statements that are not historical facts, including statements about the Company's beliefs and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. A number of factors could cause actual results to differ materially from those contained in any forward-looking statement, including but not limited to the following: the recognition of the Company's Amazfit-branded products; the Company's growth strategies; trends and competition in global wearable technology market; changes in the Company's revenues and certain cost or expense accounting policies; governmental policies relating to the Company's industry and general economic conditions around the globe. Further information regarding these and other risks is included in the Company's filings with the United States Securities and Exchange Commission. All information provided in this press release and in the attachments is as of the date of this press release, and the Company undertakes no obligation to update any forward-looking statement, except as required under applicable law. For investor and media inquiries, please contact: In China:Zepp Health CorporationGrace Yujia ZhangEmail: ir@ Piacente Financial CommunicationsTel: +86-10-6508-0677Email: zepp@ Zepp Health Corporation UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS (Amounts in thousands of U.S. dollars ("US$") except for number of shares and per share data, or otherwise noted)As of December 31,As of March 31, 20242025 US$US$Assets Current assets: Cash and cash equivalents91,06976,429 Restricted cash19,66627,408 Accounts receivable, net62,96552,896 Amounts due from related parties2,6632,581 Inventories, net56,78964,136 Short-term investments9971,002 Prepaid expenses and other current assets17,41518,003 Total current assets251,564242,455Property, plant and equipment, net6,8986,506 Intangible asset, net7,09115,220 Goodwill9,5819,581 Long-term investments225,910218,035 Deferred tax assets17,46517,488 Amount due from related parties, non-current2,0192,031 Other non-current assets4,6074,386 Operating lease right-of-use assets3,4583,051 Total assets528,593518,753 Zepp Health Corporation UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS - CONTINUED (Amounts in thousands of U.S. dollars ("US$") except for number of shares and per share data, or otherwise noted)As of December 31, As of March 31, 20242025 US$US$Liabilities Current liabilities: Accounts payable51,07760,742 Advance from customers197237 Amount due to related parties2,4771,036 Accrued expenses and other current liabilities37,57635,259 Income tax payables508506 Notes payable61,67978,452 Short-term bank borrowings41,85336,105 Total current liabilities195,367212,337 Deferred tax liabilities3,1173,090 Long-term borrowings75,24169,495 Other non-current liabilities133134 Non-current operating lease liabilities2,0071,662 Total liabilities275,865286,718 Zepp Health Corporation UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS - CONTINUED (Amounts in thousands of U.S. dollars ("US$") except for number of shares and per share data, or otherwise noted) As of December 31,As of March 31, 20242025 US$US$Equity Ordinary shares2626 Additional paid-in capital278,116278,775 Treasury stock(14,993)(15,450) Accumulated retained earnings28,6188,877 Accumulated other comprehensive loss(40,178)(40,193) Total Zepp Health Corporation shareholders' equity251,589232,035 Noncontrolling interest1,139- Total equity252,728232,035 Total liabilities and equity528,593518,753 Zepp Health Corporation UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Amounts in thousands of U.S. dollars ("US$") except for number of shares and per share data, or otherwise noted)For the Three Months Ended March 31, 20242025 US$US$Revenues39,95738,537 Cost of revenues(25,257)(24,176) Gross profit14,70014,361 Operating expenses: Selling and marketing(10,769)(13,841) General and administrative(6,420)(6,518) Research and development(13,421)(12,377) Total operating expenses(30,610)(32,736) Operating loss(15,910)(18,375) Other income and expenses: Interest income1,012581 Interest expense (1,443)(1,358) Other income/(expense), net684 Gain/(loss) from fair value change of long-term investments2,103(125) Loss before income tax and loss from equity method investments (14,170)(19,273) Income tax expenses(72)(110) Loss before loss from equity method investments(14,242)(19,383) Net loss from equity method investments(559)(358) Net loss(14,801)(19,741) Less: Net loss attributable to noncontrolling interest(32)- Net loss attributable to Zepp Health Corporation(14,769)(19,741)Basic and diluted net loss per share attributable to Zepp Health Corporation (0.06)(0.08)Basic and diluted net loss per ADS (16 ordinary shares equal to 1 ADS) (0.91)(1.23)Weighted average number of shares used in computing basic and diluted net loss per share259,525,679256,410,171 Zepp Health Corporation Reconciliation of GAAP and Non-GAAP Results (Amounts in thousands of U.S. dollars ("US$") except for number of shares and per share data, or otherwise noted)For the Three Months Ended March 31, 20242025 US$US$Total operating expenses(30,610)(32,736) Share-based compensation expenses2,283589 Amortization of intangible assets resulting from acquisitions and business cooperation agreements567635 Total adjusted operating expenses(27,760)(31,512)Operating loss(15,910)(18,375) Share-based compensation expenses2,283589 Amortization of intangible assets resulting from acquisitions and business cooperation agreements567635 Adjusted operating loss(13,060)(17,151)Net loss(14,801)(19,741) Share-based compensation expenses2,283589 Amortization of intangible assets resulting from acquisitions and business cooperation agreements567635 (Gain)/loss from fair value change of long-term investments(2,103)125 Loss from equity method investments559358 Income tax expenses72110 Interest income(1,012)(581) Interest expense 1,4431,358 Adjusted EBIT(12,992)(17,147)Net loss attributable to Zepp Health Corporation(14,769)(19,741) Share-based compensation expenses2,283589 Amortization of intangible assets resulting from acquisitions and business cooperation agreements567635 (Gain)/loss from fair value change of long-term investments(2,103)125 Loss from equity method investments559358 Tax effects on non-GAAP adjustments(91)(103) Adjusted net loss attributable to Zepp Health Corporation(13,554)(18,137)Adjusted basic and diluted net loss per share attributable to Zepp Health Corporation[5] (0.05) (0.07)Adjusted basic and diluted net loss per ADS (16 ordinary shares equal to 1 ADS) (0.84) (1.13)Weighted average number of shares used in computing adjusted basic and diluted net loss per share 259,525,679 256,410,171Share-based compensation expenses included are follows: Selling and marketing25042 General and administrative1,060286 Research and development973261 Total2,283589[5] Adjusted diluted net income/(loss) is the abbreviation of adjusted net (loss)/income attributable to Zepp Health Corporation, which is a non-GAAP measure and excludes (i) share-based compensation expenses, (ii) amortization of intangible assets resulting from acquisitions and business cooperation agreements, (iii) gain/(loss) from fair value change of long-term investment, (iv) impairment loss from long-term investments, and (v) income/(loss) from equity method investments, and (vi) tax effects of the above non-GAAP adjustments, and is used as the numerator in computation of adjusted basic and diluted net loss per ADS attributable to Zepp Health Corporation. View original content: SOURCE Zepp Health Corp.
